Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 7/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | PIM1 | P11309 | 1/20 | 0.44 |
| ▸ | PTGDR2 | Q9Y5Y4 | 5/20 | 0.44 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.43 |
| ▸ | PTGDR | Q13258 | 2/20 | 0.43 |
| ▸ | PTGIR | P43119 | 1/20 | 0.43 |
| ▸ | MAP2 | P11137 | 1/20 | 0.42 |
| ▸ | CTSA | P10619 | 1/20 | 0.40 |
| ▸ | SLC26A3 | P40879 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5157966 | 0.91 | CYP2C9 (0.81) | CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL5161705 | 0.90 | CYP2C9 (0.87) | CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL5161367 | 0.87 | CYP2C9 (1.00) | CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL5159637 | 0.86 | CYP2C9 (0.76) | CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL5159376 | 0.86 | CYP2C9 (0.89) | CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL5159266 | 0.85 | CYP2C9 (0.69) | CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL14580606 | 0.85 | CYP2C9 (0.67) | CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL7487055 | 0.84 | CYP2C9 (0.73) | CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL5157415 | 0.84 | CYP2C9 (0.73) | CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL5157433 | 0.83 | CYP2C9 (0.75) | CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1133474-B1 | 3-SUBSTITUTED-4-ARYLQUINOLIN-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2007-02-21 | — | — | EP | disclosed |
| EP-1133474-A4 | 3-SUBSTITUTED-4-ARYLQUINOLIN-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2005-02-16 | — | — | EP | disclosed |
| EP-1133474-A1 | 3-SUBSTITUTED-4-ARYLQUINOLIN-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-09-19 | — | — | EP | disclosed |
| US-6184231-B1 | NEUROPROTECTANTS; TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, TRAUMATIC BRAIN INJURY, SEXUAL DYSFUNCTION | BRISTOL-MYERS SQUIBB | 2001-02-06 | — | — | US | disclosed |
| WO-2000034244-A1 | 3-SUBSTITUTED-4-ARYLQUINOLIN-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-06-15 | — | — | WO | disclosed |